ENZUREM-40

Enzurem-40 is an advanced oral anti-cancer medication formulated with Enzalutamide 40 mg, specifically designed for the effective management of prostate cancer in adult men. It belongs to a class of medicines known as androgen receptor inhibitors, which play a crucial role in slowing down the progression of prostate cancer by targeting the hormonal pathways responsible for tumor growth.

Prostate cancer is largely driven by male hormones called androgens, such as testosterone. These hormones bind to androgen receptors in cancer cells and stimulate their growth and spread. Enzurem-40 works by blocking these androgen receptors, thereby preventing the hormones from fueling cancer cell activity. This mechanism not only inhibits tumor growth but also helps in delaying disease progression, even in patients whose cancer no longer responds to traditional hormone-lowering therapies.